These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 11496325)

  • 1. Prognostic value of plasma transforming growth factor-beta in patients with glioblastoma multiforme.
    Hulshof MC; Sminia P; Barten-Van Rijbroek AD; Gonzalez Gonzalez D
    Oncol Rep; 2001; 8(5):1107-10. PubMed ID: 11496325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased concentrations of transforming growth factor beta1 and beta2 in the plasma of patients with glioblastoma.
    Schneider T; Sailer M; Ansorge S; Firsching R; Reinhold D
    J Neurooncol; 2006 Aug; 79(1):61-5. PubMed ID: 16614941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic and prognostic value of preoperative combined GFAP, IGFBP-2, and YKL-40 plasma levels in patients with glioblastoma.
    Gállego Pérez-Larraya J; Paris S; Idbaih A; Dehais C; Laigle-Donadey F; Navarro S; Capelle L; Mokhtari K; Marie Y; Sanson M; Hoang-Xuan K; Delattre JY; Mallet A
    Cancer; 2014 Dec; 120(24):3972-80. PubMed ID: 25139333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of plasma transforming growth factor-beta levels in radiotherapy for non-small-cell lung cancer.
    De Jaeger K; Seppenwoolde Y; Kampinga HH; Boersma LJ; Belderbos JS; Lebesque JV
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1378-87. PubMed ID: 15050313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of tamoxifen on the secretion of transforming growth factor-beta2 (TGF-beta2) in glioblastomas: in vitro and in vivo findings.
    Puchner MJ; Köppen JA; Zapf S; Knabbe C; Westphal M
    Anticancer Res; 2002; 22(1A):45-51. PubMed ID: 12017331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential Expression and Clinical Significance of Transforming Growth Factor-Beta Isoforms in GBM Tumors.
    Roy LO; Poirier MB; Fortin D
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29642484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic impact of hemoglobin level prior to radiotherapy on survival in patients with glioblastoma.
    Odrazka K; Petera J; Kohlova T; Dolezel M; Vaculikova M; Zouhar M; Malek V; Hobza V; Latr I; Nemecek S; Sercl M; Ryska P; Blaha M; Cermakova E
    Strahlenther Onkol; 2003 Sep; 179(9):615-9. PubMed ID: 14628127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum long noncoding RNA HOTAIR as a novel diagnostic and prognostic biomarker in glioblastoma multiforme.
    Tan SK; Pastori C; Penas C; Komotar RJ; Ivan ME; Wahlestedt C; Ayad NG
    Mol Cancer; 2018 Mar; 17(1):74. PubMed ID: 29558959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of plasma d-dimer levels in patients with glioblastoma multiforme - Results from a pilot study.
    Hoke M; Dieckmann K; Koppensteiner R; Schillinger M; Marosi C; Mlekusch W
    Wien Klin Wochenschr; 2011 Apr; 123(7-8):199-203. PubMed ID: 21442202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantification of transforming growth factor-beta in biological material using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct.
    van Waarde MA; van Assen AJ; Kampinga HH; Konings AW; Vujaskovic Z
    Anal Biochem; 1997 Apr; 247(1):45-51. PubMed ID: 9126369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of neutrophil-lymphocyte ratio in prognosis of glioblastoma multiforme.
    Lopes M; Carvalho B; Vaz R; Linhares P
    J Neurooncol; 2018 Jan; 136(1):173-180. PubMed ID: 29076002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative biomarkers of tumour vascularity are elevated in patients with glioblastoma multiforme.
    Bennett IE; Guo H; Kountouri N; D'abaco GM; Hovens CM; Moffat BA; Desmond P; Drummond K; Kaye AH; Morokoff AP
    J Clin Neurosci; 2015 Nov; 22(11):1802-8. PubMed ID: 26308396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor-beta plasma dynamics and post-irradiation lung injury in lung cancer patients.
    Novakova-Jiresova A; Van Gameren MM; Coppes RP; Kampinga HH; Groen HJ
    Radiother Oncol; 2004 May; 71(2):183-9. PubMed ID: 15110452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of TGF-β signaling by the TGFβR-I kinase inhibitor LY2109761 enhances radiation response and prolongs survival in glioblastoma.
    Zhang M; Kleber S; Röhrich M; Timke C; Han N; Tuettenberg J; Martin-Villalba A; Debus J; Peschke P; Wirkner U; Lahn M; Huber PE
    Cancer Res; 2011 Dec; 71(23):7155-67. PubMed ID: 22006998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surrogate markers predict angiogenic potential and survival in patients with glioblastoma multiforme.
    Greenfield JP; Jin DK; Young LM; Christos PJ; Abrey L; Rafii S; Gutin PH
    Neurosurgery; 2009 May; 64(5):819-26; discussion 826-7. PubMed ID: 19404145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative expression of serum biomarkers involved in angiogenesis and inflammation, in patients with glioblastoma multiforme: correlations with clinical data.
    Chiorean R; Berindan-Neagoe I; Braicu C; Florian IS; Leucuta D; Crisan D; Cernea V
    Cancer Biomark; 2014; 14(2-3):185-94. PubMed ID: 24878820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of the Glasgow Prognostic Score for glioblastoma multiforme patients treated with radiotherapy and temozolomide.
    Topkan E; Selek U; Ozdemir Y; Yildirim BA; Guler OC; Ciner F; Mertsoylu H; Tufan K
    J Neurooncol; 2018 Sep; 139(2):411-419. PubMed ID: 29696530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance and Prognostic Value of The Coagulation Profile in Patients with Glioblastoma: Implications for Personalized Therapy.
    Navone SE; Guarnaccia L; Locatelli M; Rampini P; Caroli M; La Verde N; Gaudino C; Bettinardi N; Riboni L; Marfia G; Campanella R
    World Neurosurg; 2019 Jan; 121():e621-e629. PubMed ID: 30292037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidermal growth factor receptor amplification does not have prognostic significance in patients with glioblastoma multiforme.
    Quan AL; Barnett GH; Lee SY; Vogelbaum MA; Toms SA; Staugaitis SM; Prayson RA; Peereboom DM; Stevens GH; Cohen BH; Suh JH
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):695-703. PubMed ID: 15936158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of temozolomide treatment used at the same time with radiotherapy and adjuvant temozolomide; concomitant therapy of glioblastoma multiforme: multivariate analysis and other prognostic factors.
    Birol Sarica F; Tufan K; Cekinmez M; Sen O; Cem Onal H; Mertsoylu H; Topkan E; Pehlivan B; Erdogan B; Nur Altinors M
    J Neurosurg Sci; 2010 Mar; 54(1):7-19. PubMed ID: 20436394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.